Skip to main content

Diagnostic options Β· UAE

Microbiology tests in Dubai & UAE

Compare available Microbiology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

299

Listed price range

490.00–5,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Microbiology test prices

Showing 241–255 of 299 matching tests.

Microbiology diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-905
Rapid AFB Culture‑Based Drug Susceptibility Testing (5‑Drug Panel) Test

This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to five first-line antitubercular drugs.

Pure isolate of Mycobacterium tuberculosis complex 21 days from receipt of pure growth 1,300.00 AED
View
View test specifications and preparation
What it measures
["Susceptibility to Isoniazid", "Susceptibility to Rifampicin", "Susceptibility to Ethambutol", "Susceptibility to Pyrazinamide", "Susceptibility to Streptomycin"]
Parameters
[]
Preparation
["No patient preparation is needed as the test uses a pure laboratory isolate."]
Indications
["Suspected tuberculosis", "Need for drug susceptibility testing", "Detection of multidrug-resistant tuberculosis (MDR-TB)", "Guiding antitubercular therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100321-1 ICD-10: A15.0
Clinical summary
This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to five first-line antitubercular drugs.
TEST-852
Rapidly Growing Nontuberculous Mycobacteria (MOTT) Drug Susceptibility Testing (DST) Test

This test evaluates the susceptibility of rapidly growing nontuberculous mycobacteria isolates to a panel of antibiotics using broth microdilution.

Pure mycobacterial isolate on solid (LΓΆwenstein‑Jensen) or liquid (MGIT) media 5–7 business days from isolate receipt 1,500.00 AED
View
View test specifications and preparation
What it measures
["Minimum Inhibitory Concentration (MIC) of antibiotics", "Antibiotic susceptibility"]
Parameters
[{"name": "Amikacin", "reference_range": null}, {"name": "Cefoxitin", "reference_range": null}, {"name": "Ciprofloxacin", "reference_range": null}, {"name": "Clarithromycin", "reference_range": null}, {"name": "Doxycycline", "reference_range": null}, {"name": "Imipenem", "reference_range": null}, {"name": "Linezolid", "reference_range": null}, {"name": "Moxifloxacin", "reference_range": null}, {"name": "Tigecycline", "reference_range": null}, {"name": "Tobramycin", "reference_range": null}]
Preparation
["No patient preparation is needed as the test is performed on a cultured isolate."]
Indications
["Suspected or confirmed infection with rapidly growing NTM", "Need for targeted antibiotic therapy", "Monitoring treatment response"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 62396-3 ICD-10: A31.9
Clinical summary
This test evaluates the susceptibility of rapidly growing nontuberculous mycobacteria isolates to a panel of antibiotics using broth microdilution.
TEST-3024
Respiratory Comprehensive Panel Test

This test identifies over 30 respiratory pathogens (viral, bacterial, fungal) using multiplex qPCR and whole genome sequencing.

Throat/Nasal swab, Sputum, Bronchoalveolar Lavage (BAL) 48–72 hours (Mon-Wed-Fri batch processing) 2,700.00 AED
View
View test specifications and preparation
What it measures
["Presence of viral RNA/DNA", "Presence of bacterial RNA/DNA", "Presence of fungal RNA/DNA", "Pathogen strain identification", "Antiviral resistance markers"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of current medications (antibiotics, antivirals, immunosuppressants)"]
Indications
["Diagnosis of respiratory infections", "Identification of specific pathogens in severe or complex cases", "Monitoring for antimicrobial resistance", "Evaluation of immunocompromised patients", "Ruling out co-infections"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100384-2 ICD-10: J06.9
Clinical summary
This test identifies over 30 respiratory pathogens (viral, bacterial, fungal) using multiplex qPCR and whole genome sequencing.
TEST-2987
Respiratory Panel 1 Test

This test identifies common respiratory pathogens, including viruses and bacteria, from a patient sample.

Throat swab, Nasal swab (VTM), Sputum (β‰₯3 mL), Bronchoalveolar Lavage (BAL) fluid 24–48 Hours 800.00 AED
View
View test specifications and preparation
What it measures
["Presence of specific viral nucleic acids", "Presence of specific bacterial nucleic acids", "Presence of atypical organism nucleic acids"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9% (ISO 9001:2015 Validated)"}]
Preparation
["No fasting required.", "Avoid antiseptic mouthwash, throat lozenges, or nasal sprays for at least 2 hours prior to sample collection."]
Indications
["Acute respiratory illness", "Persistent cough", "Fever of unknown origin", "Pre-procedural screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 10372-4 ICD-10: J06.9, J20.9, B34.9
Clinical summary
This test identifies common respiratory pathogens, including viruses and bacteria, from a patient sample.
TEST-3028
Respiratory Panel 2 Test

This diagnostic test evaluates for the presence of multiple respiratory pathogens, including viruses, bacteria, and fungi, using multiplex PCR and Whole Genome Sequencing.

Nasal swab, throat swab, sputum, or BAL fluid 24–72 hours from sample receipt 850.00 AED
View
View test specifications and preparation
What it measures
["Viral RNA/DNA", "Bacterial DNA", "Fungal DNA", "Antibiotic resistance genes (e.g., mecA)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the healthcare provider about current medications"]
Indications
["Suspected respiratory infection", "Severe respiratory illness", "Need for pathogen identification for targeted therapy", "Infection control surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96966-4 ICD-10: J06.9
Clinical summary
This diagnostic test evaluates for the presence of multiple respiratory pathogens, including viruses, bacteria, and fungi, using multiplex PCR and Whole Genome Sequencing.
TEST-2988
Respiratory Panel 3 Test

This test detects and differentiates over 20 viral, bacterial, and atypical respiratory pathogens.

Throat / Nasal Swab, Sputum, or Bronchoalveolar Lavage (BAL) 48 hours from sample receipt 850.00 AED
View
View test specifications and preparation
What it measures
["SARS-CoV-2", "Influenza A/B", "Respiratory Syncytial Virus (RSV)", "Adenovirus", "Human Metapneumovirus", "Parainfluenza types 1–4", "Rhinovirus", "Mycoplasma pneumoniae", "Chlamydia pneumoniae", "Legionella pneumophila", "Bordetella pertussis", "Antimicrobial resistance gene markers (mecA, blaCTX-M)"]
Parameters
[]
Preparation
["No fasting required.", "Avoid antiseptic mouthwashes for at least two hours before throat swab collection.", "Gently blow nose before nasal swab collection.", "Rinse mouth with water only before sputum collection; do not use toothpaste or mouthwash."]
Indications
["Acute respiratory infection", "Symptomatic individuals", "Differential diagnosis of respiratory pathogens", "Guidance for antimicrobial therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88556-4 ICD-10: J06.9, J20.9, J98.5
Clinical summary
This test detects and differentiates over 20 viral, bacterial, and atypical respiratory pathogens.
TEST-3033
Respiratory Panel 4 Test

This test identifies common viral and bacterial pathogens responsible for respiratory infections.

Throat Swab, Nasal Swab, Sputum 24–48 hours 850.00 AED
View
View test specifications and preparation
What it measures
["Influenza A/B", "RSV", "Adenovirus", "Mycoplasma pneumoniae", "SARS-CoV-2", "Atypical strains via WGS"]
Parameters
[]
Preparation
["No fasting required", "Avoid mouthwash or nasal sprays for one hour prior to collection"]
Indications
["Diagnosis of respiratory infections", "Differentiation between viral and bacterial causes", "Guiding antimicrobial therapy", "Identifying specific pathogens like Influenza, RSV, SARS-CoV-2, Mycoplasma pneumoniae"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88094-6 ICD-10: J06.9, B97.89, U07.1
Clinical summary
This test identifies common viral and bacterial pathogens responsible for respiratory infections.
TEST-3039
Respiratory Panel 6 Test

This test identifies six common respiratory viruses using molecular methods.

Nasal Swab, Sputum, or Bronchoalveolar Lavage (BAL) 48 hours 850.00 AED
View
View test specifications and preparation
What it measures
["Influenza A", "Influenza B", "Respiratory Syncytial Virus (RSV)", "SARS-CoV-2", "Adenovirus", "Parainfluenza"]
Parameters
[]
Preparation
["No special preparation required", "Inform phlebotomist of nasal trauma, recent surgery, or bleeding disorders"]
Indications
["Suspected viral respiratory infection", "Differential diagnosis of respiratory symptoms", "Infection control surveillance", "Guiding antimicrobial therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80563-1 ICD-10: J06.9
Clinical summary
This test identifies six common respiratory viruses using molecular methods.
TEST-2996
Respiratory Panel 7 Test

This diagnostic test evaluates for the presence of seven common respiratory pathogens, including viruses and bacteria, in upper or lower respiratory specimens.

Upper respiratory specimen (nasopharyngeal swab) or lower respiratory specimen (sputum) 48-72 hours post receipt (reports Tue/Thu/Sat) 850.00 AED
View
View test specifications and preparation
What it measures
["Influenza A/B", "Respiratory Syncytial Virus (RSV)", "Adenovirus", "Parainfluenza virus", "Mycoplasma pneumoniae", "Chlamydia pneumoniae"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of acute respiratory infection", "Differentiation between viral and bacterial causes", "Identification of specific pathogens for targeted therapy", "Epidemiological surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 58768-2 ICD-10: J06.9
Clinical summary
This diagnostic test evaluates for the presence of seven common respiratory pathogens, including viruses and bacteria, in upper or lower respiratory specimens.
TEST-3042
Respiratory Panel 8 Test

This diagnostic test evaluates for the presence of eight common respiratory pathogens using molecular detection.

Throat/Nasal swab, sputum; BAL requires hospital setting 48 hours from sample collection 850.00 AED
View
View test specifications and preparation
What it measures
["Influenza A", "Influenza B", "RSV", "SARS-CoV-2", "Adenovirus", "Parainfluenza 1-3", "Human Metapneumovirus"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of respiratory infections", "Differentiation between viral and bacterial causes", "Guiding antiviral therapy", "Infection control measures"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60568-4 ICD-10: J00, J22
Clinical summary
This diagnostic test evaluates for the presence of eight common respiratory pathogens using molecular detection.
TEST-3000
Respiratory Pathogen Panel 9 (RPP9) Test

This diagnostic test evaluates for the presence of nine common respiratory pathogens using multiplex PCR and WGS.

Nasopharyngeal swab, sputum, or bronchoalveolar lavage (BAL) 24–48 hours (reports delivered Tue/Thu/Sat) 2,500.00 AED
View
View test specifications and preparation
What it measures
["Influenza A", "Influenza B", "RSV", "SARS-CoV-2", "Adenovirus", "Parainfluenza 1-3", "Human Metapneumovirus", "Mycoplasma pneumoniae"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist of recent antiviral medication or respiratory vaccines (within 14 days)", "Continue prescribed medications unless advised otherwise by physician", "Parent or legal guardian must be present for children"]
Indications
["Suspected respiratory infection", "Differentiation between common respiratory pathogens", "Identification of co-infections", "Epidemiological surveillance", "Guiding targeted therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 54118-9 ICD-10: J06.9, B34.9, B97.89
Clinical summary
This diagnostic test evaluates for the presence of nine common respiratory pathogens using multiplex PCR and WGS.
TEST-640
Respiratory Syncytial Virus B (RSV-B) Viral Load Quantitative Test

This test measures the quantity of RSV-B viral RNA in a respiratory sample using qPCR.

Nasopharyngeal Swab 48 hours (email) / 36 hours (phone) 1,000.00 AED
View
View test specifications and preparation
What it measures
["RSV-B viral RNA quantity", "Viral load"]
Parameters
[]
Preparation
["Avoid using nasal sprays or decongestants for 2 hours before sample collection", "Continue any prescribed medications"]
Indications
["Monitoring antiviral therapy", "Managing high-risk patients", "Epidemiological surveillance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77433-0 ICD-10: B97.4
Clinical summary
This test measures the quantity of RSV-B viral RNA in a respiratory sample using qPCR.
TEST-3020
Rickettsia Antibody Panel Test

This test detects IgM and IgG antibodies against various Rickettsia species, aiding in the diagnosis of current or past rickettsial infections.

Serum 2–3 weeks (batch processing; sample must arrive by the 7th of the month) 3,000.00 AED
View
View test specifications and preparation
What it measures
["IgM antibodies to typhus and spotted fever group rickettsiae", "IgG antibodies to typhus and spotted fever group rickettsiae"]
Parameters
[{"name": "Rickettsia IgM Antibodies", "reference_range": null}, {"name": "Rickettsia IgG Antibodies", "reference_range": null}]
Preparation
["No special preparation needed", "Complete mandatory Test Send Out Consent Form (Form 35)"]
Indications
["Clinical suspicion of rickettsial illness", "Exposure history in endemic areas", "Diagnosis of acute or past rickettsial infection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 31703-8 ICD-10: A75.9
Clinical summary
This test detects IgM and IgG antibodies against various Rickettsia species, aiding in the diagnosis of current or past rickettsial infections.
TEST-56
RNA Viral Metagenome Sequencing Data Analysis Test

This test identifies RNA viruses, including novel strains, from a whole blood sample using next-generation sequencing.

Whole blood (3 mL minimum) or extracted DNA 4 weeks 3,000.00 AED
View
View test specifications and preparation
What it measures
["Presence of RNA viruses", "Viral genetic material"]
Parameters
[]
Preparation
["No special preparation required", "Share recent antiviral therapy or immunomodulatory medication history"]
Indications
["Investigating oncoviruses", "Exploring viral triggers of autoimmune flares", "Biomarker discovery in complex infectious presentations", "Diagnosing complex or undiagnosed infections"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 88516-1 ICD-10: B34.9
Clinical summary
This test identifies RNA viruses, including novel strains, from a whole blood sample using next-generation sequencing.
TEST-3025
Rocky Mountain Spotted Fever Antibodies (IgG, IgM) Test

This diagnostic test evaluates the presence and levels of IgG and IgM antibodies against Rickettsia rickettsii in the patient's serum.

Serum (peripheral blood) 2–3 weeks after monthly batch cut-off (7th of each month) 1,800.00 AED
View
View test specifications and preparation
What it measures
["IgG antibodies against Rickettsia rickettsii", "IgM antibodies against Rickettsia rickettsii"]
Parameters
[{"name": "IgG Antibodies", "reference_range": null}, {"name": "IgM Antibodies", "reference_range": null}]
Preparation
["No special preparation is required.", "Complete the mandatory Test Send Out Consent Form (Form 35)."]
Indications
["Suspected acute RMSF infection", "Confirmation of past RMSF infection", "Evaluation of patients with fever, headache, and rash after tick exposure"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51712-5 ICD-10: A77.0, Z11.8, Z20.89
Clinical summary
This diagnostic test evaluates the presence and levels of IgG and IgM antibodies against Rickettsia rickettsii in the patient's serum.

Category overview

Microbiology: overview

Uncovering the hidden causes of illness is the essential first step toward targeted treatment and restoring your peace of mind. The Microbiology division at DNA Labs UAE employs advanced automated culturing and antimicrobial susceptibility technologies to identify specific microscopic pathogens accurately. By pinpointing the exact bacteria or fungi involved, our comprehensive microbiology testing in the UAE serves as a vital guide for your doctor’s clinical decision-making. Operating as a premier diagnostic lab in Dubai/UAE, we guarantee the highest standards of data security and strict confidentiality, delivering fast, highly accurate results you can rely on. Take the guesswork out of your recovery. Browse our microbiology diagnostic tests, schedule a convenient home collection, or speak with our laboratory experts today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area